You look at a flower or resin label, and three acronyms pop up: CBD, CBG, CBN. Three letters that change each time, as if the plant spoke a dialect you’ve never had translated. Good news: these are not exotic synthetic molecules or lab-made derivatives. They are three natural cannabinoids from hemp, cousins from the same family, but with distinct origins and profiles. Once you understand their differences, you’ll choose a product for what it does, not for the flashy acronym on the package.
What exactly is a cannabinoid?
A cannabinoid is a molecule produced by the hemp plant that interacts with the human endocannabinoid system, a network of receptors present throughout the body. Over 100 have been identified in cannabis. CBD, CBG, and CBN are among them, just like THC—the difference lies in how each acts and what it triggers, or doesn't.
The common point of all three: none are psychoactive in the sense of THC. You don't get high, you don't lose control, you don't miss your day. This is precisely what makes them interesting for an ex-THC user seeking calm without the high. Where it gets complicated is that each has a different biological history—and it's this history that explains their profiles.
Three molecules, three moments in the plant's life
The simplest way to remember the difference is to think of a timeline. CBG appears first: it's the starting point. CBD (and THC) then form from CBG during growth. CBN comes last: it forms when THC ages and degrades. Beginning, middle, end—three stages of the same plant.
CBD, CBG, CBN: the differences table
Here's the essential at a glance. This table compares their origin in the plant, typical abundance, research-described effects, psychoactivity, and French legality. Keep in mind that none of these three will make you "high": the nuances concern the feeling, not an alteration of consciousness.
| Criterion | CBD | CBG | CBN |
|---|---|---|---|
| Full Name | Cannabidiol | Cannabigerol | Cannabinol |
| Origin in the plant | Formed during growth | Precursor ("mother molecule") | Result of THC aging |
| Typical Abundance | High (up to 15-25%) | Low (often < 1%) | Low, increases with flower age |
| Effects described by research | Calming, relaxation, most documented | Anxiety/mood, anti-inflammatory (preclinical) | Reputed for evening, limited clinical evidence |
| THC-like psychoactivity | No | No | Very low, no comparison to THC |
| Legal in France (hemp < 0.3% THC) | Yes | Yes | Yes |
The described effects come from preclinical research and the first available clinical trials. They do not constitute medical advice or a promise of results. See the sources block at the bottom of the page.
The anti-scam reflex
CBD, CBG, and CBN are natural cannabinoids, extracted from a flower. Not to be confused with HHC, H4CBD, or "CBD+" which are semi-synthetic derivatives produced by chemical reaction. If a store mixes these two families in the same argument, it's a red flag. We detail why we refuse these derivatives in our guide hemp derivatives: HHC, H4CBD, legality and risks.
CBG, the mother molecule
CBG (cannabigerol) is the precursor to all other cannabinoids: in its acidic form (CBGA), it is from this that the plant synthesizes CBD, THC, and the rest. Hence its nickname "mother molecule." Paradoxically, because it transforms into something else during growth, it often remains present at less than 1% in the mature flower, making it rare and more expensive to extract.
What recent research says about CBG
In 2024, the first controlled human clinical trial tested 20 mg of hemp-derived CBG on 34 healthy adults. Participants reported a decrease in perceived anxiety 20, 45, and 60 minutes after intake, with no signs of intoxication or cognitive slowing (Cuttler et al., Scientific Reports, 2024). This is an encouraging first step, but a single small trial does not make an established truth.
On the preclinical side (lab, animal models), CBG is studied for anti-inflammatory, antioxidant, and neuroprotective properties. These avenues still need to be confirmed in humans on a larger scale.
In practice, CBG primarily interests those seeking an alternative to CBD for daytime use: early user feedback suggests a "clear" profile, without drowsiness. But be honest with yourself—we're talking about a cannabinoid still young in science, whose biology is better understood than its optimal daily use.
CBN, born from aging THC
CBN (cannabinol) is not produced directly by the plant: it appears when THC oxidizes and degrades under the effect of time, heat, and light. An old flower forgotten in a drawer therefore contains more CBN than a fresh flower. It is the "end-of-life" cannabinoid of the THC molecule—and it retains very low psychoactivity, incomparable to that of THC.
CBN and sleep: what we really know
CBN has a reputation as a "sleep cannabinoid." This needs an honest nuance. In 2024, the most robust objective study, conducted at the University of Sydney, showed that CBN increases sleep—but in rats, not yet in humans. A small human trial in 2023 (20 mg, single dose) observed fewer nocturnal awakenings in a limited sample. In short: the avenue is serious, but clinical evidence remains limited. We elaborate on this topic in our dedicated guide CBD for sleep in 2026.
That's why, when we offer a product oriented for evening use, it's rarely associated with CBN alone. Our CBD 10% + CBN 5% + melatonin oil, for example, combines CBN with melatonin, whose role in sleep induction is better documented. The idea is never to oversell a miracle molecule, but to assemble a coherent profile for a given moment.
Why they are combined: the entourage effect
Isolated, these cannabinoids each have a modest effect. Together, they act synergistically: this is the entourage effect, described as early as 2011 by researcher Ethan Russo (Br J Pharmacol, 2011). The idea: the feeling from a product is not simply the sum of its molecules taken separately. CBD, CBG, CBN, and terpenes interact with each other.
This is exactly what happens in our Mousseux CBN, a resin that features CBD (11%), CBG (6%), and CBN (25%): the three cannabinoids from this article, combined in one natural product. A good example of a "complete" profile rather than a monomolecular isolate. To understand why a full extract is not like a purified isolate, see our comparison full spectrum, broad spectrum, or isolate.
Terpenes—the aromatic molecules of the flower—also contribute to this synergy. Two products with the same CBD content can feel different depending on their terpene profile. We delve into this mechanism in the article CBD terpenes: myrcene, limonene, pinene.
How to choose between CBD, CBG, and CBN?
The right question isn't "which is best?" but "which for which moment?". None of the three is absolutely superior: they address different intentions. Here is an honest guide, always to be cross-referenced with your own feelings.
| Your Intention | Cannabinoid to consider | At Cloud Store |
|---|---|---|
| Discovering CBD, general calming | CBD, the most versatile and documented | CBD flowers, resins, and oils |
| Daytime, staying clear and composed | CBD, possibly CBG | CBD oils, "daytime" profiles |
| Evening, end-of-day ritual | CBN + melatonin (blend) | CBD + CBN + melatonin oil |
| Complete profile, several cannabinoids | CBD + CBG + CBN combined | Mousseux CBN (resin) |
Our field advice
Start with CBD; it's the logical entry point: it's the most studied, easiest to dose, and serves as your benchmark. If you then want to explore a "daytime" or "evening" profile, consider CBG and CBN as variations, not replacements. And always read the label: a good product displays its concentrations and a certificate of analysis. We explain how to decipher it in how to read a CBD oil label.
Is it legal in France?
Yes. CBD, CBG, and CBN are legal in France as long as they are derived from hemp compliant with the 0.3% THC threshold set by regulations. None of these three natural cannabinoids are classified as narcotics. It is their origin (authorized hemp) and the THC content of the final product that determine legality, not the acronym itself.
The distinction that truly matters lies elsewhere: between these natural cannabinoids and semi-synthetic derivatives like HHC, H4CBD, or HHCPO, whose status is precarious or prohibited and which do not present the same safety profile. We commit to only referencing natural products. For the complete legal framework, see our guide to legal CBD in France in 2026.
Want to try a complete profile, with CBD, CBG, and CBN combined in a natural product rather than an isolate? All our resins and oils clearly display their levels. Shipped within 24 hours.
Discover Mousseux CBNFAQ — CBD, CBG, and CBN
Do CBG or CBN get you high like THC?
No. CBG has no THC-like psychoactivity. CBN has very low psychoactivity, not comparable to THC: we are not talking about a "high" effect or loss of control. Like CBD, these two cannabinoids aim for calming, not getting high. They are legal in France under the 0.3% THC threshold.
What's the real difference between CBD, CBG, and CBN?
Their place in the plant's life cycle. CBG is the precursor, the "mother molecule" from which others are formed. CBD forms during growth and remains the most abundant. CBN appears last, when THC ages and degrades. Three stages, three profiles, but all natural and non-intoxicating.
Does CBN really help with sleep?
CBN is reputed for evening use, but clinical evidence remains limited. The most robust objective study in 2024 (University of Sydney) showed an effect on sleep in rats, not yet in humans. A small human trial in 2023 observed fewer nocturnal awakenings. The lead is serious, but not an established certainty.
Is CBG better than CBD?
Neither better nor worse: different. CBD is the most versatile and well-documented. CBG, rarer and more expensive to extract, is the subject of promising recent research on anxiety (human trial 2024, 34 adults), but with much less hindsight. See it as a variation to explore once CBD is familiar, not as a replacement.
Can CBD, CBG, and CBN be taken together?
Yes, and this is often the case. A full-spectrum extract or complete resin naturally contains several cannabinoids that act synergistically, the entourage effect described by Russo in 2011. Our Mousseux CBN, for example, combines CBD (11%), CBG (6%), and CBN (25%) in the same natural product.
CBD, CBG, CBN: which are legal in France?
All three. They are natural cannabinoids from hemp, authorized as long as the final product respects the 0.3% THC threshold. None are classified as narcotics. The red line is elsewhere: semi-synthetic derivatives like HHC or H4CBD, with a precarious or prohibited status, which we do not reference.
Why is CBG more expensive than CBD?
Because it's rare. CBG is the precursor to other cannabinoids: the plant transforms it during its growth, so often less than 1% remains in the mature flower. Extracting a usable amount of CBG therefore requires more raw material, which is reflected in the final price.
Information for educational purposes, updated July 15, 2026. The effects described in this article are derived from preclinical research and the first available clinical trials; they do not constitute medical advice or a promise of results. For any health concerns, consult a healthcare professional.
- Cuttler C. et al., "Acute effects of cannabigerol on anxiety, stress, and mood," Scientific Reports (Nature), 2024 — accessed 07/15/2026 — nature.com/articles/s41598-024-66879-0
- University of Sydney (Lambert Initiative), "First objective study to show cannabinol increases sleep," November 2024 — accessed 07/15/2026 — sydney.edu.au
- Russo E.B., "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects," British Journal of Pharmacology, 2011 — accessed 07/15/2026 — bpspubs.onlinelibrary.wiley.com
- World Health Organization (WHO), "Cannabidiol (CBD) Critical Review Report," Expert Committee on Drug Dependence, 2018 — framework for CBD's tolerance and lack of abuse potential.